| European Case Law Identifier: | ECLI:EP:BA:1999:T086298.19990817 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 17 August 1999 | ||||||||
| Case number: | T 0862/98 | ||||||||
| Application number: | 87116861.3 | ||||||||
| IPC class: | G01N 1/10 G01N 35/00 G01F 11/02 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Apparatus and process for reagent fluid dispensing and printing | ||||||||
| Applicant name: | Abbott Laboratories | ||||||||
| Opponent name: | Roche Diagnostics GmbH | ||||||||
| Board: | 3.4.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Unclear situation of the file: substantive oral decision or intention announced Infringement of Rule 68(2) EPC: substantial procedural violation Change in composition of Opposition Division: obligation to offer new oral proceedings |
||||||||
| Catchwords: |
Changes in the composition of an Opposition Division after oral proceedings should be generally avoided also in cases where no final substantive decision has been given orally. Where this is not possible, new oral proceedings must in general be offered to the parties under such circumstances (see the analogous regulation of Article 7(1) of the Rules of Procedure of the Boards of Appeal). Such offers may be foregone in exceptional cases, in particular if the final decision given by a differently composed Opposition Division is not substantially based on findings arrived at during the oral proceedings but on fresh facts and arguments communicated to the parties in the resumed written proceedings (see point 2.3 of the reasons). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t980862eu1.html
Date retrieved: 17 May 2021